Motivazione e Neurotrasmettitori nei Canottieri
Correlati Psicobiologici della Motivazione al Successo e Risposte Neurotrasmettitoriali all'Esercizio Fisico nei Canottieri d'Elite
The goal of this observational study is to learn how motivation and body chemistry are linked during and after intense exercise in national-level rowers.
The main questions this study aims to answer are:
Do athletes with higher motivation show different changes in brain chemicals after exercise? How do hormone and neurotransmitter levels change during recovery after exercise?
Participants will:
Complete a motivation questionnaire called the Inventory of Achievement Motivation (LMI) before the exercise test.
Perform a 6000-meter rowing test on an indoor rowing machine. Have blood samples taken three times: before exercise, immediately after exercise, and 1 hour after exercise.
Researchers will measure blood levels of testosterone, cortisol, serotonin, dopamine, beta-endorphin, anandamide (AEA), and 2-arachidonoylglycerol (2-AG).
This study will help researchers understand how motivation and body chemistry work together to influence performance and recovery in highly trained athletes.
Panoramica dello studio
Stato
Stato
Condizioni
Condizioni
Intervento / Trattamento
Intervento / Trattamento
Descrizione dettagliata
This study explores how motivation and body chemistry are connected during and after intense physical exercise in national-level rowers. Researchers want to understand how psychological factors, such as motivation to achieve goals, relate to changes in hormones and brain chemicals that occur with exercise and recovery.
Before the exercise test, participants will complete a motivation questionnaire called the Inventory of Achievement Motivation (LMI). This questionnaire helps identify how strongly a person is driven to perform, overcome challenges, and reach success.
After the questionnaire, each participant will complete a 6000-meter rowing test on an indoor rowing machine. This test is designed to produce a high level of physical effort similar to competition conditions. Blood samples will be taken three times: before the test, immediately after the test, and one hour after recovery.
The blood samples will be used to measure levels of several hormones and neurotransmitters, including testosterone, cortisol, serotonin, dopamine, beta-endorphin, anandamide (AEA), and 2-arachidonoylglycerol (2-AG). These substances are involved in stress response, motivation, reward, and recovery.
Researchers will compare the results from the motivation questionnaire with changes in hormone and neurotransmitter levels. The goal is to find out whether more motivated athletes show different chemical responses to exercise and recovery.
Findings from this study may improve understanding of how the mind and body interact during intense training. This knowledge could help athletes and coaches develop better ways to support motivation, performance, and recovery in high-level sports.
Tipo di studio
Tipo di studio
Iscrizione (Effettivo)
Iscrizione
Contatti e Sedi
Luoghi di studio
-
-
Greater Poland Voivodeship
-
Poznan, Greater Poland Voivodeship, Polonia, 61-871
- Poznań University of Physical Education
-
-
Criteri di partecipazione
Criteri di ammissibilità
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Metodo di campionamento
Popolazione di studio
All participants were recruited and tested at the Central Sports Centre - Olympic Preparation Center (COS OPO) in Wałcz, Poland, during a national team training camp under standardized conditions.
Descrizione
Inclusion Criteria:
National-level male rowers Age between 18 and 25 years Minimum of 3 years of systematic rowing training Regular training load (at least 10 sessions per week during the competitive season) Good general health and medical clearance for maximal exercise testing
Exclusion Criteria:
Current illness, injury, or infection Use of medications or dietary supplements that could affect hormone or neurotransmitter levels Smoking or use of psychoactive substances Inadequate sleep or food intake before testing Refusal or inability to provide informed consent
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Modelli osservazionali: COHORT
- Prospettive temporali: RETROSPECTIVE
Numero di gruppi/coorti
Coorti e interventi
Gruppo / CoorteGruppo / Coorte |
Intervento / TrattamentoIntervento / Trattamento |
|---|---|
|
Rowers
The study includes 24 national-level male rowers. All participants are healthy, highly trained athletes with at least 3 years of systematic rowing experience and regular intensive training. |
Participants perform a 6000-meter rowing test on an indoor ergometer at maximal effort to simulate race conditions and induce physiological fatigue. |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Changes in serum Cortisol levels
Lasso di tempo: Before exercise, immediately after, and 1 hour after recovery
|
Measurement of Cortisol serum concentrations (ng/mL). |
Before exercise, immediately after, and 1 hour after recovery
|
|
Changes in serum Testosterone levels
Lasso di tempo: Before exercise, immediately after, and 1 hour after recovery
|
Measurement of Testosterone serum concentrations (ng/mL). |
Before exercise, immediately after, and 1 hour after recovery
|
|
Changes in serum Dopamin levels
Lasso di tempo: Before exercise, immediately after, and 1 hour after recovery
|
Measurement of Dopamin serum concentrations (ng/mL). |
Before exercise, immediately after, and 1 hour after recovery
|
|
Changes in serum Serotonin levels
Lasso di tempo: Before exercise, immediately after, and 1 hour after recovery
|
Measurement of Serotonin serum concentrations (ng/mL). |
Before exercise, immediately after, and 1 hour after recovery
|
|
Changes in serum Beta-endorphin levels
Lasso di tempo: Before exercise, immediately after, and 1 hour after recovery
|
Measurement of Beta-endorphin serum concentrations (ng/mL). |
Before exercise, immediately after, and 1 hour after recovery
|
|
Changes in serum anandamide (AEA) levels
Lasso di tempo: Before exercise, immediately after, and 1 hour after recovery
|
Measurement of anandamide (AEA) serum concentrations (ng/mL). |
Before exercise, immediately after, and 1 hour after recovery
|
|
Changes in serum 2-arachidonoylglycerol (2-AG)) levels
Lasso di tempo: Before exercise, immediately after, and 1 hour after recovery
|
Measurement of 2-arachidonoylglycerol (2-AG) serum concentrations (ng/mL). |
Before exercise, immediately after, and 1 hour after recovery
|
Misure di risultato secondarie
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Changes in Testosterone-to-cortisol ratio (T:C)
Lasso di tempo: Before exercise, immediately after, and 1 hour after recovery
|
Ratio calculated from serum testosterone and cortisol concentrations (ng/mL), used as an indicator of anabolic-catabolic balance. |
Before exercise, immediately after, and 1 hour after recovery
|
|
Changes in TSerotonin-to-dopamine ratio (S:D)
Lasso di tempo: Before exercise, immediately after, and 1 hour after recovery
|
Ratio of serum serotonin to dopamine concentrations (ng/mL), reflecting neurochemical balance related to motivation and fatigue. |
Before exercise, immediately after, and 1 hour after recovery
|
|
Achievement Motivation (LMI score)
Lasso di tempo: Before exercise (baseline)
|
Assessment of achievement motivation using the Inventory of Achievement Motivation (LMI). The questionnaire evaluates multiple dimensions of motivation, such as persistence, confidence in success, goal setting, and compensatory effort. Total and subscale scores are analyzed to identify individual motivational profiles. |
Before exercise (baseline)
|
Collaboratori e investigatori
Sponsor
Sponsor
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Inizio studio
Completamento primario (Effettivo)
Completamento primario
Completamento dello studio (Effettivo)
Completamento dello studio
Date di iscrizione allo studio
Primo inviato
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Primo Inserito
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento pubblicato
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
Altri numeri di identificazione dello studio
- LMI60002023
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Descrizione del piano IPD
Individual participant data (IPD) will not be shared. Data will be used only for internal analysis and dissemination in scientific publications in aggregate form, in accordance with ethical approval.
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .